CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings Call Highlights: Navigating Revenue ...

By Yahoo! Finance   |   1 month ago
CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings Call Highlights: Navigating Revenue ...

AbbVie is reviewing interim results from dermal filler trials, with no specific update date yet. $2 million payment received recently, with no estimated milestone payments for 2025.

Read More

Did you find this insightful?